Understanding the gap between good processes of diabetes care and poor intermediate outcomes Translating Research into Action for Diabetes (TRIAD)

Medical Care

Volumn 45, Issue 12, 2007, Pages 1144-1153

  Selhy, Joe V ^a,b   Swain, Bix E ^a   Gerzoff, Robert B ^b   Karter, Andrew J ^a   Waitzfelder, Beth E ^c   Brown, Arleen F ^d   Ackermann, Ronald T ^e   Duru, O Kenrik ^d   Ferrara, Assiamira ^a   Herman, William ^f   Marrero, David G ^e   Caputo, Dorothy ^g   Narayan, K M Venkat ^h,i  

^a TRIAD Study Group

^b DIVISION OF RESEARCH   (United States)

^c NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^d PACIFIC HEALTH RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f INDIANA UNIVERSITY   (United States)

^g UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^h University of Medicine and Dentistry of New Jersey   (United States)

ⁱ EMORY UNIVERSITY   (United States)

Author keywords

Diabetes mellitus; Disparities; Hyperlipidemias; Hypertension; Quality of health care; Socioeconomic factors

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; ETHNOLOGY; FEMALE; HEALTH BEHAVIOR; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTOR; SEX DIFFERENCE; SOCIOECONOMICS; TREATMENT OUTCOME;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HEALTH BEHAVIOR; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); RISK FACTORS; SEX FACTORS; SOCIOECONOMIC FACTORS;

EID: 36248998850     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLR.0b013e3181468e79     Document Type: Article

References (52)

1. Saaddine JB, Cadwell B, Gregg EW, et al. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med. 2006;144:465-474.
2. NCQA HEDIS measures for commercial and medicare populations 2000-2005. Available at: http://www.ncqa.org/Docs/SOHCQ_2005.pdf. Accessed August 9, 2006.
3. Jamtvedt G, Young JM, Kristoffersen DT, et al. Audit and feedback: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2003;(3):CD000259.
4. Renders CM, Valk GD, Griffin SJ, et al. Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review. Diabetes Care. 2001;24:1821-1833.
5. Norris SL, Nichols PJ, Caspersen CJ, et al. The effectiveness of disease and case management for people with diabetes. A systematic review. Am J Prev Med. 2002;22(4 Suppl): 15-38.
6. Mangione CM, Gerzoff RB, Williamson DF, et al. Association of Diabetes Disease Management Programs' Intensity with Process and Outcomes Measures of Quality of Care: The Translating Research into Action for Diabetes (TRIAD) Study. Ann Intern Med. 2006;145:107-116.
7. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291:335-342.
8. The TRIAD Study Group. The Translating Research into Action for Diabetes (TRIAD) Study. Diabetes Care 2002;25:386-389.
9. Frankel L. The report of the CASRO Task Force on response rates. In: Wiseman F, ed. Improving Data Quality in a Sample Survey. Cambridge, MA: Marketing Science Institute; 1983.
10. Brazier J, Jones N, Kind P. Testing the validity of the EuroQOL and comparing it with the SF-36 health survey questionnaire. Qual Life Res. 1993;2:169-180.
11. Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220-233.
12. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
13. Katz JN, Chang LC, Sangha O, et al. Can comorbidity be measured by questionnaire rather than medical record review? Med Care. 1996;34: 73-84.
14. Spitzer RL, Kroenke K, Williams JBW, et al. Validation and utility of a self-report version of PRIME-MD. JAMA. 1999;282:1737-1744.
15. Corson K, Gerrity MS, Dobscha SK. Screening for depression and suicidality in a VA primary care setting: 2 items are better than 1 item. Am J Manag Care. 2004;10(Part 2):839-845.
16. Harper S, Lynch J, Hsu WL, et al. Life course socioeconomic conditions and adult psychosocial functioning. Int J Epidemiol. 2002;31:395-403.
17. Safran DG, Kosinski M, Tarlov AR, et al. The Primary Care Assessment Survey: tests of data quality and measurement performance. Med Care. 1998;36:728-739.
18. Thorn DH, Hall MA, Pawlson LG. Measuring patients' trust in physicians when assessing quality of care. Health Aff (Millwood). 2004;23: 124-132.
19. Hargraves JL, Hays RD, Cleary PD. Psychometric Properties of the Consumer Assessment of Health Plans Study (CAHPS®) 2. 0 Adult Core Survey. Health Serv Res. 2003;38(6 Pt 1):1509-1528.
20. Rubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med. 1991;10:585-598.
21. Ackermann RT, Thompson TJ, Selby JV, et al. Is the number of documented diabetes process-of-care indicators associated with cardiometabolic risk factor levels, patient satisfaction, or self-rated quality of diabetes care. Diabetes Care. 2006;29:2108-2113.
22. Duru OK, Mangione CM, Steers NW, et al. The association between clinical care strategies and the attenuation of racial/ethnic disparities in diabetes care: the Translating Research Into Action for Diabetes (TRIAD) Study. Med Care. 2006;44:1121-1128.
23. Jotkowitz AB, Rabinowitz G, Segal AR, et al. Do patients with diabetes and low socioeconomic status receive less care and have worse outcomes. Am J Med. 2006;119:665-669.
24. Martin TL, Selby JV, Zhang D. Physician and patient prevention practices in NIDDM in a large urban managed-care organization. Diabetes Care. 1995;18:1124-1132.
25. Gary TL, McGuire M, McCauley J, et al. Racial comparisons of health care and glycémie control for African American and white diabetic adults in an urban managed care organization. Dis Manag. 2004;7:25-34.
26. Adams AS, Zhang F, Mah C, et al. Race differences in long-term diabetes management in an HMO. Diabetes Care. 2005;28:2844-2849.
27. Kirk JK, D'Agostino RB Jr, Bell RA, et al. Disparities in HbA1c levels between African-American and Non-Hispanic white adults with diabetes: a meta-analysis. Ann Pharmacother. 2005;39:1489-1501.
28. Brown AF, Gregg EW, Stevens MR, et al. Race, ethnicity, socioeconomic position, and quality of care for adults with diabetes enrolled in managed care: the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care. 2005;28:2864-2870.
29. Heisler M, Smith DM, Hayward RA, et al. Racial disparities in diabetes care processes, outcomes, and treatment intensity. Med Care. 2003;41: 1221-1232.
30. Safford M, Eaton L, Hawley G, et al. Disparities in use of lipid-lowering medications among people with type 2 diabetes mellitus. Arch Intern Med. 2003;163:922-928.
31. Chaturvedi N, Stephenson JM, Fuller JH. The relationship between socioeconomic status and diabetes control and complications in the EURODIAB IDDM Complications Study. Diabetes Care. 1996;19:423-430.
32. Karter AJ, Ferrara A, Darbinian J, et al. Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. Diabetes Care. 2000;23:477-483.
33. Schillinger D, Barton LR, Karter AJ, et al. Does literacy mediate the relationship between education and health outcomes? A study of a low-income population with diabetes. Public Health Rep. 2006;121: 245-254.
34. Brown AF, Ettner SL, Piette J, Weinberger et al. Socioeconomic position and health among persons with diabetes mellitus: a conceptual framework and review of the literature. Epidemiol Rev. 2004; 26:63-77.
35. Tseng CW, Brook RH, Keeler E, et al. Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage. JAMA. 2004;292:952-960.
36. Heisler M, Wagner TH, Piette JD. Patient strategies to cope with high prescription medication costs: who is cutting back on necessities, increasing debt, or underusing medications? J Behav Med. 2005;28: 43-51.
37. Piette JD, Heisler M, Wagner TH. Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care. 2004;27:384-391.
38. Hsu J, Price M, Huang J, et al. Unintended consequences of caps on Medicare drug benefits. N Engl J Med. 2006;354:2349-2359.
39. Ferrara A, Williamson DF, Karter AJ, et al. Sex differences in quality of health care related to ischemic heart disease prevention in patients with diabetes: the translating research into action for Diabetes (TRIAD) study, 2000-2001. Diabetes Care. 2004;27:2974-2976.
40. Ferrara A, Mangione C, Kim C, et al. Gender disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes: Translating Research into Action for Diabetes (TRIAD). Diabetes Care. In Press.
41. Safran DG, Taira DA, Rogers WH, et al. Linking primary care performance to outcomes of care. J Fam Pract. 1998;47:213-220.
42. Bonds DE, Camacho F, Bell RA, et al. The association of patient trust and self-care among patients with diabetes mellitus. BMC Fam Pract. 2004;5:26.
43. Halbert CH, Armstrong K, Gandy OH Jr, et al. Racial differeneces in trust in health care providers. Arch Intern Med. 2006;166:896-901.
44. Piette JD, Heisler M, Krein S, et al. The role of patient-physician trust in moderating medication nonadherence due to cost pressures. Arch Intern Med. 2005;165:1749-1755.
45. Karter AJ, Stevens M, Gregg E, et al. High rates of smoking among poorly educated young adults with diabetes: Translating Research into Action for Diabetes. Am J Public Health. In press.
46. Anderson .TB. Unraveling health disparities: examining the dimensions of hypertension and diabetes through community engagement. J Health Care Poor Underserved. 2005;16(4 Suppl A):91-117.
47. Shenolikar RA, Balkrishnan R, Camacho FT, et al. Race and medication adherence in Medicaid enrollees with type-2 diabetes. J Natl Med Assoc. 2006;98:1071-1077.
48. Steinman MA, Sands LP, Covinsky KE. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med. 2001;16:793-799.
49. Piette JD, Heisler M, Home R, et al. A conceptually based approach to understanding chronically ill patients' responses to medication cost pressures. Soc Sci Med. 2006;62:846-857.
50. Oliveria SA, Lapuerta P, McCarthy BD, et al. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med. 2002;162:413-420.
51. Ziemer DC, Miller CD, Rhee MK, et al. Clinical inertia contributes to poor diabetes control in a primary care setting. Diabetes Educ. 2005; 31:564-571.
52. Jackson GL, Edelman D, Weinberger M. Simultaneous control of intermediate diabetes outcomes among Veterans Affairs primary care patients. J Gen Intern Med. 2006;21:1050-1056.